The global in vitro lung model market is primarily driven by the increasing demand for safer and more effective pharmaceutical testing methods. In vitro lung models mimic the structure and function of healthy and diseased human lungs, and are used as an alternative to animal testing in drug development and toxicity testing. They help researchers better understand disease mechanisms and simulate physiological responses to identify potentially harmful or toxic drug candidates at an early stage. Compared to traditional animal testing methods, in vitro lung models offer significant advantages such as human-relevance, high-throughput screening, cost-effectiveness and ethical compliance.

The global in vitro lung model market is estimated to be valued at US$ 279.8 Mn in 2023 and is expected to exhibit a CAGR of 14.% over the forecast period 2024 to 2031, as highlighted in a new report published by Coherent Market Insights.

Market key trends:

The growing implementation of 3D bioprinting technology in developing organ-on-chip and microphysiological system models is one of the key trends driving the in vitro lung model market. Three-dimensional bioprinting allows the creation of complex 3D structures that better mimic the microenvironment of living tissues compared to traditional two-dimensional cell cultures. Furthermore, 3D bioprinted lung models can be customized for species specificity and disease modeling to serve diverse research needs. This has significantly increased their utility and commercialization potential for pharmaceutical research and development. Many market players are focusing on developing novel 3D bioprinted human lung tissue constructs to offer more realistic and predictive platforms for drug screening and toxicity assessment.

Segment Analysis

The global In Vitro Lung Model Market is segmented by product type, application, end use, and region. By product type, the market is further classified into 2D cell culture, and 3D cell culture. Among these, the 3D cell culture segment dominates the market and accounts for the highest share. 3D cell culture models closely mimic the actual lung microenvironment and architecture, which helps in better replication of physiologically relevant responses.

Key Takeaways

The global In Vitro Lung Model market is expected to witness high growth over the forecast period from 2024 to 2031.

Regional analysis shows that North America region currently dominates the market and is expected to continue its dominance over the forecast period. Factors such as increasing research funding for drug discovery and development, and presence of major players in the region are driving the market growth.

Key players operating in the global In Vitro Lung Model market include Epithelix, MATTEK, Lonza, Emulate, AlveoliX AG, Nortis, CN Bio Innovations Ltd, MIMETAS, InSphero, ATTC Global, Tissuse GmbH and Cn Bio Innovations Limited.

Get More Insights On This Topic: https://www.ukwebwire.com/in-vitro-lung-model-market-size-share-analysis-2023-2030/